中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

胆囊癌诊断和治疗指南(2015版)

中华医学会外科学分会胆道外科学组

引用本文:
Citation:

胆囊癌诊断和治疗指南(2015版)

DOI: 10.3969/j.issn.1001-5256.2016.03.002
基金项目: 

国家科技支撑计划课题(2012BAI06B01); 

详细信息
  • 中图分类号: R735.8

Guideline for the diagnosis and treatment of gallbladder carcinoma(2015 edition)

Research funding: 

 

  • 摘要:

    <正>胆囊癌是指发生于胆囊(包括胆囊底部、体部、颈部以及胆囊管)的恶性肿瘤。我国胆囊癌发病率占同期胆道疾病的0.4%3.8%,位列消化道肿瘤发病率第6位,患者5年总生存率仅为5%[1-3]。胆囊癌疗效的提高主要取决于对其主要高危因素的认识、准确的临床分期和根治性手术切除方法的应用。由于长期缺乏符合我国国情的诊断与治疗规范,目前对于胆囊癌诊断与治疗方法的认识和应用仍较为混乱。为此,中华

     

  • [1] HUNDAL R,SHAFFER EA.Gallbladder cancer:epidemiology and outcome[J].Clin Epidemiol,2014,6(6):99-109.
    [2]HUEMAN MT,VOLLMER J,PAWLIK TM.Evolving treatment strategies for gallbladder cancer[J].Ann Surg Oncol,2009,16(8):2101-2115.
    [3]ZOU SQ,ZHANG L.Clinical epidemiologic characteristics of carcinoma of gallbladder in China[J].Chin J Pract Surg,2000,20(1):43-46.(in Chinese)邹声泉,张林.全国胆囊癌临床流行病学调查报告[J].中国实用外科杂志,2000,20(1):43-46.
    [4]GUYATT GH,OXMAN AD,VIST GE,et al.GRADE:an emerging consensus on rating quality of evidence and strength of recommendations[J].BMJ,2008,336(7650):924-926.
    [5]CHEN YL,LI YP,DU L,et al.Evolution of levels of evidence and strength of recommendations in medical research[J].Chin J Evidbased Med,2008,8(2):127-133.(in Chinese)陈耀龙,李幼平,杜亮,等.医学研究中证据分级和推荐强度的演进[J].中国循证医学杂志,2008,8(2):127-133.
    [6]SCHNEL LDORFER T.Porcelain gallbladder:a benign process or concern for malignancy?[J].J Gastrointest Surg,2013,17(6):1161-1168.
    [7]CUNNINGHAM SC,ALEXANDER HR.Porcelain gallbladder and cancer:ethnicity explains a discrepant literature?[J].Am J Med,2007,120(4):e17-e18.
    [8] RANDI G,FRANCESCHI S,la VECCHIA C.Gallbladder cancer worldwide:geographical distribution and risk factors[J].Int J Cancer,2006,118(7):1591-1602.
    [9]GALLAHAN WC,CONWAY JD.Diagnosis and management of gallbladder polyps[J].Gastroenterol Clin North Am,2010,39(2):359-367.
    [10]NOMURA T,SHIRAI Y,SANDOH N,et al.Cholangiographic criteria for anomalous union of the pancreatic and biliary ducts[J].Gastrointest Endosc,2002,55(2):204-208.
    [11] STINTON LM,SHAFFER EA.Epidemiology of gallbladder disease:cholelithiasis and cancer[J].Gut Liver,2012,6(2):172-187.
    [12] GONZALEZ-ESCOBEDO G,MARSHALL JM,GUNN JS.Chronic and acute infection of the gall bladder by salmonella typhi:understanding the carrier state[J].Nat Rev Microbiol,2011,9(1):9-14.
    [13]EDGE SB,COMPTON CC.The American joint committee on cancer:the 7th edition of the AJCC cancer staging manual and the future of TNM[J].Ann Surg Oncol,2010,17(6):1471-1474.
    [14]FRED TB,FATIMA C,RAIPH HH,et al.WHO classification of tumours of the digestive system[R].International Agency for Research on Cancer,201(3):1089.
    [15]JANG JY,KIM SW,LEE SE,et al.Differential diagnostic and staging accuracies of high resolution ultrasonography,endoscopic ultrasonography,and multidetector computed tomography for gallbladder polypoid lesions and gallbladder cancer[J].Ann Surg,2009,250(6):943-949.
    [16]KUMARAN V,GULATI MS,PAUL SB,et al.The role of dualphase helical CT in assessing resectability of carcinoma of the gallbladder[J].Eur Radiol,2002,12(8):1993-1999.
    [17]KIM SJ,LEE JM,LEE JY,et al.Accuracy of preoperative T-staging of gallbladder carcinoma using MDCT[J].AJR Am J Roentgenol,2008,190(1):74-80.
    [18]TSENG JH,WAN YL,HUNG CF,et al.Diagnosis and staging of gallbladder carcinoma.Evaluation with dynamic MR imaging[J].Clin Imaging,2002,26(3):177-182.
    [19]DUTTA U.Gallbladder cancer:can newer insights improve the outcome?[J].J Gastroenterol Hepatol,2012,27(4):642-653.
    [20]WERNBERG JA,LUCARELLI DD.Gallbladder cancer[J].Surg Clin North Am,2014,94(2):343-360.
    [21]YOSHIMITSU K,HONDA H,SHINOZAKI K,et al.Helical CT of the local spread of carcinoma of the gallbladder:evaluation according to the TNM system in patients who underwent surgical resection[J].AJR Am J Roentgenol,2002,179(2):423-428.
    [22]KIM SJ,LEE JM,LEE ES,et al.Preoperative staging of gallbladder carcinoma using biliary MR imaging[J].J Magn Reson Imaging,2015,41(2):314-321.
    [23]YOSHIMITSU K,NISHIHARA Y,OKAMOTO DA,et al.Magnetic resonance differentiation between T2 and T1 gallbladder carcinoma:significance of subserosal enhancement on the delayed phase dynamic study[J].J Magn Reson Imaging,2012,30(6):854-859.
    [24]DONG JH,ZHENG SS,CHEN XP,et al.Consensus on evaluation of hepatic functional reserve before hepatectomy(2011 edition)[J].Chin J Digest Surg,2011,10(1):20-25.(in Chinese)董家鸿,郑树森,陈孝平,等.肝切除术前肝脏储备功能评估的专家共识(2011版)[J].中华消化外科杂志,2011,10(1):20-25.
    [25] Biliary Tract Group of Chinese Society of Surgery,Chinese Medical Association,Professional Committee on Hepatobiliary Surgery of the PLA.Guidelines for the diagnosis and treatment of hilar cholangiocarcinoma(2013)[J].Chin J Surg,2013,51(10):865-871.(in Chinese)中华医学会外科学分会胆道外科学组,解放军全军肝胆外科专业委员会.肝门部胆管癌诊断和治疗指南(2013版)[J].中华外科杂志,2013,51(10):865-871.
    [26]BENSON AB,D'ANGELICA MI,ABRAMS TA.Network NCC,NCCN clinical practice guidelines in oncology:hepatobiliary cancers,version2,2014[J].J Natl Compr Canc Netw,2014,12(8):1152-1182.
    [27]LEE SE,JANG JY,LIM CS,et al.Systematic review on the surgical treatment for T1 gallbladder cancer[J].World J Gastroenterol,2011,17(2):174-180.
    [28]ISAMBERT M,LEUX C,METAIRIE S,et al.Incidentally-discovered gallbladder cancer:when,why and which reoperation?[J].J Visc Surg,2011,148(2):e77-e84.
    [29]GOETZE TO,PAOLUCCI V.The prognostic impact of positive lymph nodes in stages T1 to T3 incidental gallbladder carcinoma:results of the German registry[J].Surg Endosc,2012,26(5):1382-1389.
    [30]SHIRAI Y,WAKAI T,SAKATA J,et al.Regional lymphadenectomy for gallbladder cancer:rational extent,technical details,and patient outcomes[J].World J Gastroenterol,2012,18(22):2775-2783.
    [31]GOETZE T,PAOLUCCI V.Does laparoscopy worsen prognosis for incidental gallbladder cancer?[J].Surg Endosc,2006,20(2):286-293.
    [32]MEKEEL KL,HEMMING AW.Surgical management of gallbladder carcinoma:a review[J].J Gastrointest Surg,2007,11(9):1188-1193.
    [33]KOHYA N,MIYAZAKI K.Hepatectomy of segment 4a and 5 combined with extra-hepatic bile duct resection for T2 and T3 gallbladder carcinoma[J].J Surg Oncol,2008,97(6):498-502.
    [34]ARAIDA T,HIGUCHI R,HAMANO M,et al.Should the extrahepatic bile duct be resected or preserved in R0 radical surgery for advanced gallbladder carcinoma?Results of a Japanese society of biliary surgery survey:a multicenter study[J].Surg Today,2009,39(9):770-779.
    [35]JAYARAMAN S,JARNAGIN WR.Management of gallbladder cancer[J].Gastroenterol Clin North Am,2010,39(2):331-342.
    [36]SHIMIZU H,KIMURA F,YOSHIDOME H,et al.Aggressive surgical approach for stage IV gallbladder carcinoma based on Japanese society of biliary surgery classification[J].J Hepatobiliary Pancreat Surg,2007,14(4):358-365.
    [37]NAKATA T,KOBAYASHI A,MIWA S,et al.Impact of tumor spread to the cystic duct on the prognosis of patients with gallbladder carcinoma[J].World J Surg,2007,31(1):155-163.
    [38]SASAKI K,MATSUDA M,HASHIMOTO M,et al.Early cystic duct carcinoma of new classification[J].Int J Surg Case Rep,2011,2(8):246-249.
    [39]YOKOYAMA Y,NISHIO H,EBATA T,et al.New classification of cystic duct carcinoma[J].World J Surg,2008,32(4):621-626.
    [40]FUKS D,REGIMBEAU JM,le TREUT Y,et al.Incidental gallbladder cancer by the AFC-GBC-2009 study group[J].World J Surg,2011,35(8):1887-1897.
    [41]MAKER AV,BUTTE JM,OXENBERG J,et al.Is port site resection necessary in the surgical management of gallbladder cancer?[J].Ann Surg Oncol,2012,19(2):409-417.
    [42]STEINERT R,LIPPERT H,REYMOND M.Tumor cell dissemination during laparoscopy:prevention and therapeutic opportunities[J].Dig Surg,2002,19(6):464-472.
    [43]KONDO S,TAKADA T,MIYAZAKI M,et al.Guidelines for the management of biliary tract and ampullary carcinomas:surgical treatment[J].J Hepatobiliary Pancreat Surg,2008,15(1):41-54.
    [44]PANDEY D.Surgical management of gallbladder cancer[J].Indian J Surg,2009,71(6):363-367.
    [45]TAKADA T,AMANO H,YASUDA H,et al.Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma?[J].J Cancer,2002,95(8):1685-1695.
    [46]MURAKAMI Y,UEMURA K,SUDO TA,et al.Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma[J].Ann Surg,2009,250(6):950-956.
    [47]MOJICA P,SMITH D,ELLENHORN J.Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease[J].J Surg Oncol,2007,96(1):8-13.
    [48]BALACHANDRAN P,AGARWAL S,KRISHNANI N,et al.Predictors of long-term survival in patients with gallbladder cancer[J].J Gastrointest Surg,2006,10(6):848-854.
    [49] VALLE J,WASAN H,PALMER DH,et al.Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer[J].N Engl J Med,2010,362(14):1273-1281.
    [50]MACDONALD OK,CRANE CH.Palliative and postoperative radiotherapy in biliary tract cancer[J].Surg Oncol Clin N Am,2002,11(4):941-954.
  • 加载中
计量
  • 文章访问数:  360
  • HTML全文浏览量:  31
  • PDF下载量:  2792
  • 被引次数: 0
出版历程
  • 出版日期:  2016-03-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回